rs143603619
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000299698.12(A2ML1):c.3550A>T(p.Ser1184Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00076 in 1,614,240 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000299698.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
A2ML1 | NM_144670.6 | c.3550A>T | p.Ser1184Cys | missense_variant | 29/36 | ENST00000299698.12 | NP_653271.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
A2ML1 | ENST00000299698.12 | c.3550A>T | p.Ser1184Cys | missense_variant | 29/36 | 1 | NM_144670.6 | ENSP00000299698 | P1 | |
ENST00000631830.1 | n.322-5565T>A | intron_variant, non_coding_transcript_variant | 3 | |||||||
A2ML1 | ENST00000541459.5 | c.2200A>T | p.Ser734Cys | missense_variant | 18/25 | 2 | ENSP00000443174 | |||
A2ML1 | ENST00000539547.5 | c.2077A>T | p.Ser693Cys | missense_variant | 18/25 | 2 | ENSP00000438292 |
Frequencies
GnomAD3 genomes AF: 0.00384 AC: 585AN: 152246Hom.: 4 Cov.: 34
GnomAD3 exomes AF: 0.00103 AC: 256AN: 249514Hom.: 3 AF XY: 0.000761 AC XY: 103AN XY: 135374
GnomAD4 exome AF: 0.000439 AC: 642AN: 1461876Hom.: 5 Cov.: 29 AF XY: 0.000371 AC XY: 270AN XY: 727240
GnomAD4 genome AF: 0.00384 AC: 585AN: 152364Hom.: 4 Cov.: 34 AF XY: 0.00370 AC XY: 276AN XY: 74508
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 22, 2019 | Variant summary: A2ML1 c.3550A>T (p.Ser1184Cys) results in a non-conservative amino acid change located in the Alpha-macroglobulin-like, TED domain (IPR011626) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0013 in 280918 control chromosomes, predominantly at a frequency of 0.014 within the African or African-American subpopulation in the gnomAD database, including 3 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 3500 fold of the estimated maximal expected allele frequency for a pathogenic variant in A2ML1 causing Noonan Syndrome and Related Conditions phenotype (4e-06), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.3550A>T in individuals affected with Noonan Syndrome and Related Conditions and no experimental evidence demonstrating its impact on protein function have been reported. Two ClinVar submissions (evaluation after 2014) cite the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 15, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at